Patents by Inventor Mark J. Mescher

Mark J. Mescher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10913925
    Abstract: The systems and methods disclosed herein are generally related to a cell culture system. More particularly, the systems and methods enable the culturing and interconnecting of a plurality of tissue types in a biomimetic environment. By culturing organ specific tissue types within a biomimetic environment and interconnecting each of the organ systems in a physiologically meaningful way, experiments can be conducted on in vitro cells that substantially mimic the responses of in vivo cell populations. In some implementations, the system is used to monitor how organ systems respond to agents such as toxins or medications. The system enables the precise and controlled delivery of these agents, which, in some implementations, enables the biomimetic dosing of drugs in humans to be mimicked.
    Type: Grant
    Filed: November 23, 2016
    Date of Patent: February 9, 2021
    Assignees: The Charles Stark Draper Laboratory, Inc., The Massachusetts Institute of Technology
    Inventors: Joseph Cuiffi, Jeffrey T. Borenstein, Anilkumar Harapanahalli Achyuta, Mark J. Mescher, Linda Griffith, Samuel Walker Inman
  • Patent number: 9764121
    Abstract: An implantable drug delivery apparatus for delivering a drug into a bodily fluid in a bodily cavity of a patient over a period of time includes a drug supply reservoir to supply drug into a delivery channel and an actuator for delivering the drug to a predetermined location in the bodily cavity of the patient, such as, for example, a cochlea of a human ear. The drug is loaded into the delivery channel while producing substantially negligible flow at an outlet of the delivery channel.
    Type: Grant
    Filed: November 3, 2014
    Date of Patent: September 19, 2017
    Assignees: THE CHARLES STARK DRAPER LABORATORY, INC., MASSACHUSETTS EYE AND EAR INFIRMARY
    Inventors: Jason O. Fiering, Mark J. Mescher, Erin E. Pararas, Jeffrey T. Borenstein, William F. Sewell, Sharon G. Kujawa, Michael J. McKenna, Ernest S. Kim
  • Publication number: 20170137768
    Abstract: The systems and methods disclosed herein are generally related to a cell culture system. More particularly, the systems and methods enable the culturing and interconnecting of a plurality of tissue types in a biomimetic environment. By culturing organ specific tissue types within a biomimetic environment and interconnecting each of the organ systems in a physiologically meaningful way, experiments can be conducted on in vitro cells that substantially mimic the responses of in vivo cell populations. In some implementations, the system is used to monitor how organ systems respond to agents such as toxins or medications. The system enables the precise and controlled delivery of these agents, which, in some implementations, enables the biomimetic dosing of drugs in humans to be mimicked.
    Type: Application
    Filed: November 23, 2016
    Publication date: May 18, 2017
    Inventors: Joseph Cuiffi, Jeffrey T. Borenstein, Anilkumar Harapanahalli Achyuta, Mark J. Mescher, Linda Griffith, Samuel Walker Inman
  • Patent number: 9651166
    Abstract: A microfluidic valve system includes a substrate, a valve seat a compliant membrane and a mechanically actuable displacement element. The substrate includes first and second channels embedded within it and includes a first layer of material and a second layer of material. The valve seat is in fluid communication with the first and second channels. Portions of the second layer of material form sidewalls of the second channel and the valve seat. The mechanically actuable displacement element applies a mechanical force to the compliant membrane to bring the compliant membrane into sealable contact with the valve seat, thereby closing the valve system.
    Type: Grant
    Filed: February 26, 2015
    Date of Patent: May 16, 2017
    Assignee: The Charles Stark Draper Laboratory, Inc.
    Inventors: Mark J. Mescher, Jason O. Fiering, Erin E. Swan
  • Patent number: 9528082
    Abstract: The systems and methods disclosed herein are generally related to a cell culture system. More particularly, the systems and methods enable the culturing and interconnecting of a plurality of tissue types in a biomimetic environment. By culturing organ specific tissue types within a biomimetic environment and interconnecting each of the organ systems in a physiologically meaningful way, experiments can be conducted on in vitro cells that substantially mimic the responses of in vivo cell populations. In some implementations, the system is used to monitor how organ systems respond to agents such as toxins or medications. The system enables the precise and controlled delivery of these agents, which, in some implementations, enables the biomimetic dosing of drugs in humans to be mimicked.
    Type: Grant
    Filed: July 25, 2013
    Date of Patent: December 27, 2016
    Assignees: The Charles Stark Draper Laboratory, Inc., The Massachusetts Institute of Technology
    Inventors: Joseph Cuiffi, Jeffrey T. Borenstein, Anilkumar Harapanahalli Achyuta, Mark J. Mescher, Linda Griffith, Samuel Walker Inman
  • Patent number: 9293821
    Abstract: In various embodiments, an actuating mechanism is employed to displace a conductor disposed within a fluidic channel, thereby reconfiguring an electronic component.
    Type: Grant
    Filed: July 8, 2010
    Date of Patent: March 22, 2016
    Assignee: The Charles Stark Draper Laboratory, Inc.
    Inventors: Amy E. Duwel, Jason O. Fiering, Douglas W. White, Mark J. Mescher, Joseph M. Bauer, John R. Lachapelle, Bryan Mclaughlin, Frans Spaepen
  • Publication number: 20160003229
    Abstract: A variable, closed-loop apparatus for regulating a microfluidic flow that employs a low-power deflection assembly, which is surface-mounted over a flexible membrane overlying a chamber integrated into a microfabricated platform. A flexible membrane, movable between two positions, sealingly overlies the chamber. One of the positions of the membrane restricts the flow through the chamber to a greater degree than the other position. A deflection assembly disposed on the substrate over the membrane unidirectionally deflects the membrane, thereby regulating the flow through the chamber.
    Type: Application
    Filed: July 9, 2015
    Publication date: January 7, 2016
    Inventors: Mark J. Mescher, Jason O. Fiering, Christopher E. Dube
  • Patent number: 9180054
    Abstract: An implantable drug delivery apparatus for delivering a drug into a bodily fluid in a body cavity of a patient over a period of time includes a variable-volume vessel defining a working chamber for receiving a drug and recirculating a therapeutic fluid. The fluid can contain a bodily fluid, such as, for example, perilymph, and a drug. The device allows for the controlled delivery of the therapeutic fluid to a predetermined location in the bodily cavity of the patient, such as, for example, a cochlea of a human ear.
    Type: Grant
    Filed: January 6, 2011
    Date of Patent: November 10, 2015
    Assignees: The Charles Stark Draper Laboratory, Inc., Massachusetts Eye and Ear Infirmary
    Inventors: Jason O. Fiering, Mark J. Mescher, Sharon G. Kujawa, Michael J. McKenna, William F. Sewell
  • Publication number: 20150167863
    Abstract: A microfluidic device may include a substrate that defines a flow-control cavity and first and second channels in fluid communication with the flow-control cavity. A compliant membrane for regulating fluid flow through the flow-control cavity may surround at least a portion of the flow-control cavity.
    Type: Application
    Filed: February 26, 2015
    Publication date: June 18, 2015
    Inventors: Mark J. Mescher, Jason O. Fiering, Erin E. Swan
  • Publication number: 20150157837
    Abstract: An implantable drug delivery apparatus for delivering a drug into a bodily fluid in a bodily cavity of a patient over a period of time includes a drug supply reservoir to supply drug into a delivery channel and an actuator for delivering the drug to a predetermined location in the bodily cavity of the patient, such as, for example, a cochlea of a human ear. The drug is loaded into the delivery channel while producing substantially negligible flow at an outlet of the delivery channel.
    Type: Application
    Filed: November 3, 2014
    Publication date: June 11, 2015
    Inventors: Jason O. Fiering, Mark J. Mescher, Erin E. Pararas, Jeffrey T. Borenstein, William F. Sewell, Sharon G. Kujawa, Michael J. McKenna, Ernest S. Kim
  • Patent number: 9046192
    Abstract: A microfluidic device may include a substrate that defines a flow-control cavity and first and second channels in fluid communication with the flow-control cavity. A compliant membrane for regulating fluid flow through the flow-control cavity may surround at least a portion of the flow-control cavity.
    Type: Grant
    Filed: January 31, 2008
    Date of Patent: June 2, 2015
    Assignee: The Charles Stark Draper Laboratory, Inc.
    Inventors: Mark J. Mescher, Jason O. Fiering, Erin E. Swan
  • Patent number: 8999123
    Abstract: Electrodes are positioned substantially in contact with at least one surface of a solid to generate or absorb alkali metals when a voltage is applied between the electrodes.
    Type: Grant
    Filed: April 12, 2010
    Date of Patent: April 7, 2015
    Assignee: The Charles Stark Draper Laboratory, Inc.
    Inventors: Jonathan J. Bernstein, Mark J. Mescher, William L. Robbins
  • Patent number: 8876795
    Abstract: An implantable drug delivery apparatus for delivering a drug into a bodily fluid in a bodily cavity of a patient over a period of time includes a drug supply reservoir to supply drug into a delivery channel and an actuator for delivering the drug to a predetermined location in the bodily cavity of the patient, such as, for example, a cochlea of a human ear. The drug is loaded into the delivery channel while producing substantially negligible flow at an outlet of the delivery channel.
    Type: Grant
    Filed: February 2, 2012
    Date of Patent: November 4, 2014
    Assignees: The Charles Stark Draper Laboratory, Inc., Massachusetts Eye and Ear Infirmary
    Inventors: Jason O. Fiering, Mark J. Mescher, Erin E. Pararas, Jeffrey T. Borenstein, William F. Sewell, Sharon G. Kujawa, Michael J. McKenna, Ernest S. Kim
  • Publication number: 20140030752
    Abstract: The systems and methods disclosed herein are generally related to a cell culture system. More particularly, the systems and methods enable the culturing and interconnecting of a plurality of tissue types in a biomimetic environment. By culturing organ specific tissue types within a biomimetic environment and interconnecting each of the organ systems in a physiologically meaningful way, experiments can be conducted on in vitro cells that substantially mimic the responses of in vivo cell populations. In some implementations, the system is used to monitor how organ systems respond to agents such as toxins or medications. The system enables the precise and controlled delivery of these agents, which, in some implementations, enables the biomimetic dosing of drugs in humans to be mimicked.
    Type: Application
    Filed: July 25, 2013
    Publication date: January 30, 2014
    Inventors: Joseph Cuiffi, Jeffrey T. Borenstein, Anilkumar Harapanahalli Achyuta, Mark J. Mescher, Linda Griffith, Samuel Walker Inman
  • Patent number: 8605374
    Abstract: A varifocal optical system includes a substantially circular membrane deposited on a substrate, and a ring-shaped PZT thin film deposited on the outer portion of the circular membrane. The membrane may be a MEMS-micromachined membrane, made of thermal oxide, polysilicon, ZrO2 and SiO2. The membrane is initially in a buckled state, and may function as a mirror or a lens. Application of an electric voltage between an inner and outer electrode on the piezoelectric thin film induces a lateral strain on the PZT thin film, thereby altering the curvature of the membrane, and thus its focal length. Focal length tuning speeds as high as 1 MHz have been demonstrated. Tuning ranges of several hundred microns have been attained. The varifocal optical system can be used in many applications that require rapid focal length tuning, such as optical switching, scanning confocal microscopy, and vibration compensation in optical storage disks.
    Type: Grant
    Filed: November 1, 2010
    Date of Patent: December 10, 2013
    Assignee: The Charles Stark Draper Laboratory, Inc.
    Inventor: Mark J. Mescher
  • Publication number: 20130053823
    Abstract: An implantable drug delivery apparatus for delivering a drug into a bodily fluid in a bodily cavity of a patient over a period of time includes a drug supply reservoir to supply drug into a delivery channel and an actuator for delivering the drug to a predetermined location in the bodily cavity of the patient, such as, for example, a cochlea of a human ear. The drug is loaded into the delivery channel while producing substantially negligible flow at an outlet of the delivery channel.
    Type: Application
    Filed: February 2, 2012
    Publication date: February 28, 2013
    Inventors: Jason O. Fiering, Mark J. Mescher, Erin E. Pararas, Jeffrey T. Borenstein, William F. Sewell, Sharon G. Kujawa, Michael J. McKenna, Ernest S. Kim
  • Patent number: 8292083
    Abstract: A method and apparatus for continuously separating or concentrating particles that includes flowing two fluids in laminar flow through a magnetic field gradient which causes target particles to migrate to a waste fluid stream, and collecting each fluid stream after being flowed through the magnetic field gradient.
    Type: Grant
    Filed: April 18, 2008
    Date of Patent: October 23, 2012
    Assignees: The Charles Stark Draper Laboratory, Inc., Children's Medical Center Corporation
    Inventors: Mathew Varghese, Jason O. Fiering, Donald E. Ingber, Nan Xia, Mark J. Mescher, Jeffrey T. Borenstein, Chong Wing Yung
  • Publication number: 20120007778
    Abstract: In various embodiments, an actuating mechanism is employed to displace a conductor disposed within a fluidic channel, thereby reconfiguring an electronic component.
    Type: Application
    Filed: July 8, 2010
    Publication date: January 12, 2012
    Inventors: Amy E. Duwel, Jason O. Fiering, Douglas W. White, Mark J. Mescher, Joseph M. Bauer, John R. Lachapelle, Bryan McLaughlin, Frans Spaepen
  • Publication number: 20110295194
    Abstract: An implantable drug delivery apparatus for delivering a drug into a bodily fluid in a body cavity of a patient over a period of time includes a variable-volume vessel defining a working chamber for receiving a drug and recirculating a therapeutic fluid. The fluid can contain a bodily fluid, such as, for example, perilymph, and a drug. The device allows for the controlled delivery of the therapeutic fluid to a predetermined location in the bodily cavity of the patient, such as, for example, a cochlea of a human ear.
    Type: Application
    Filed: January 6, 2011
    Publication date: December 1, 2011
    Inventors: Jason O. Fiering, Mark J. Mescher, Sharon G. Kujawa, Michael J. McKenna, William F. Sewell
  • Publication number: 20110247942
    Abstract: Electrodes are positioned substantially in contact with at least one surface of a solid to generate or absorb alkali metals when a voltage is applied between the electrodes.
    Type: Application
    Filed: April 12, 2010
    Publication date: October 13, 2011
    Inventors: Jonathan J. Bernstein, Mark J. Mescher, William L. Robbins